1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
Article

Extraskeletal osteosarcoma. A European Musculoskeletal Oncology Society study on 266 patients

Longhi, A., Bielack, S. S., Grimer, R., Whelan, J., Windhager, R., Leithner, A., Gronchi, A., Biau, D., Jutte, P. C., Krieg, A. H., Klenke, F. M., Grignani, G., Donati, D. M., Capanna, R., Casanova, J., Gerrand, C., Bisogno, G., Hecker-Nolting, S., Lisa, M., D'Ambrosio, L. & 3 others, Willegger, M., Scoccianti, G. & Ferrari, S., Mar 1 2017, In : European Journal of Cancer. 74, p. 9-16 8 p.

Research output: Contribution to journalArticle

Ex vivo allogeneic stimulation significantly improves expansion of cytokine-Induced killer cells without increasing their alloreactivity across HLA barriers

Todorovic, M., Mesiano, G., Gammaitoni, L., Leuci, V., Giraudo Diego, L., Cammarata, C., Jordaney, N., Carnevale-Schianca, F., Gallo, S., Fagioli, F., Piacibello, W., Elia, A. R., Pignochino, Y., Dell'Aglio, C., Grignani, G., Cignetti, A., Aglietta, M. & Sangiolo, D., Sep 2012, In : Journal of Immunotherapy. 35, 7, p. 579-586 8 p.

Research output: Contribution to journalArticle

Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma Group.

Luksch, R., Grignani, G., D'Angelo, P., Prete, A., Puma, N., Podda, M., Casanova, M., Ferrari, A., Morosi, C., Fagioli, F., Aglietta, M., Ferrari, S., Picci, P. & Massimino, M., Jun 14 2017, In : Pediatric Blood and Cancer. 64, 12, p. 1-4 4 p.

Research output: Contribution to journalArticle

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST

Urbini, M., Indio, V., Tarantino, G., Ravegnini, G., Angelini, S., Nannini, M., Saponara, M., Santini, D., Ceccarelli, C., Fiorentino, M., Vincenzi, B., Fumagalli, E., Casali, P. G., Grignani, G., Pession, A., Ardizzoni, A., Astolfi, A. & Pantaleo, M. A., Sep 2019, In : Genes Chromosomes and Cancer. 58, 9, p. 636-642 7 p.

Research output: Contribution to journalArticle

Open Access

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.

Urbini, M., Indio, V., Tarantino, G., Ravegnini, G., Angelini, S., Nannini, M., Saponara, M., Santini, D., Ceccarelli, C., Fiorentino, M., Vincenzi, B., Fumagalli, E., Casali, P. G., Grignani, G., Pession, A., Ardizzoni, A., Astolfi, A. & Pantaleo, M. A., Sep 1 2019, In : Genes Chromosomes and Cancer. 58, p. 636-642 7 p.

Research output: Contribution to journalArticle

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brodowicz, T., Broto, J. M., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Eriksson, M., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S. & 43 others, Frezza, A. M., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hannu, A., Hassan, B., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kasper, B., Kopeckova, K., Krákorová, D. A., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Pantaleo, M. A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A. L., Reichardt, P., Robinson, M. H., Rutkowski, P., Safwat, A. A., Schöffski, P., Sleijfer, S., Stacchiotti, S., Sundby Hall, K., Unk, M., Van Coevorden, F., Van Der Graaf, W., Whelan, J., Wardelmann, E., Zaikova, O. & Blay, J. Y., 2018, In : Annals of Oncology. 29, p. iv68-iv78

Research output: Contribution to journalArticle

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brodowicz, T., Broto, J. M., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Eriksson, M., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S. & 42 others, Frezza, A. M., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Hannu, A., Hassan, B., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kasper, B., Kopeckova, K., Krákorová, D. A., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Pantaleo, M. A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A. L., Reichardt, P., Robinson, M. H., Rutkovski, P., Safwat, A. A., Schoffski, P., Sleijfer, S., Stacchiotti, S., Sundby Hall, K., Unk, M., Van Coevorden, F., Van der Graaf, W., Whelan, J., Wardelmann, E., Zaikova, O. & Blay, J. Y., May 28 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, suppl 4, p. iv68-iv78 11 p.

Research output: Contribution to journalArticle

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brodowicz, T., Broto, J. M., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Eriksson, M., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S. & 45 others, Frezza, A. M., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hannu, A., Hassan, B., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kasper, B., Kopeckova, K., Krákorová, D. A., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Pantaleo, M. A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A. L., Reichardt, P., Robinson, M. H., Rutkowski, P., Safwat, A. A., Schöffski, P., Sleijfer, S., Stacchiotti, S., Sundby Hall, K., Unk, M., Van Coevorden, F., Van der Graaf, W., Whelan, J., Wardelmann, E., Zaikova, O., Blay, J. Y., Committee, ESMO. G. & [Unknown], EURACAN., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. iv68-iv78

Research output: Contribution to journalArticle

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

Palmerini, E., Jones, R. L., Marchesi, E., Paioli, A., Cesari, M., Longhi, A., Meazza, C., Coccoli, L., Fagioli, F., Asaftei, S., Grignani, G., Tamburini, A., Pollack, S. M., Picci, P. & Ferrari, S., Apr 20 2016, In : BMC Cancer. 16, 1, 8 p., 280.

Research output: Contribution to journalArticle

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

Palmerini, E., Jones, R. L., Marchesi, E., Paioli, A., Cesari, M., Longhi, A., Meazza, C., Coccoli, L., Fagioli, F., Asaftei, S. D., Grignani, G., Tamburini, A., Pollack, S. M., Picci, P. & Ferrari, S., Apr 20 2016, In : BMC Cancer. 16, 1, 280.

Research output: Contribution to journalArticle

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

Palmerini, E., Jones, R. L., Marchesi, E., Paioli, A., Cesari, M., Longhi, A., Meazza, C., Coccoli, L., Fagioli, F., Asaftei, S. D., Grignani, G., Tamburini, A., Pollack, S. M., Picci, P. & Ferrari, S., Apr 20 2016, In : BMC Cancer. 16, 1, 280.

Research output: Contribution to journalArticle

Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST

Pantaleo, M. A., Urbini, M., Indio, V., Ravegnini, G., Nannini, M., De Luca, M., Tarantino, G., Angelini, S., Gronchi, A., Vincenzi, B., Grignani, G., Colombo, C., Fumagalli, E., Gatto, L., Saponara, M., Ianni, M., Paterini, P., Santini, D., Pirini, M. G., Ceccarelli, C. & 10 others, Altimari, A., Gruppioni, E., Renne, S. L., Collini, P., Stacchiotti, S., Brandi, G., Casali, P. G., Pinna, A. D., Astolfi, A. & Biasco, G., May 1 2017, In : Molecular Cancer Research. 15, 5, p. 553-562 10 p.

Research output: Contribution to journalArticle

Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST

Pantaleo, M. A., Urbini, M., Indio, V., Ravegnini, G., Nannini, M., De Luca, M., Tarantino, G., Angelini, S., Gronchi, A., Vincenzi, B., Grignani, G., Colombo, C., Fumagalli, E., Gatto, L., Saponara, M., Ianni, M., Paterini, P., Santini, D., Pirini, M. G., Ceccarelli, C. & 10 others, Altimari, A., Gruppioni, E., Renne, S. L., Collini, P., Stacchiotti, S., Brandi, G., Casali, P. G., Pinna, A. D., Astolfi, A. & Biasco, G., May 2017, In : Molecular Cancer Research. 15, 5, p. 553-562 10 p.

Research output: Contribution to journalArticle

Gingival metastasis of a radiotherapy-induced breast angiosarcoma: Diagnosis and multidisciplinary treatment achieving a prolonged complete remission

Chiarelli, A., Boccone, P., Goia, F., Gatti, M., De Rosa, G., Manca, A., Galizia, D., Aglietta, M. & Grignani, G., Nov 2012, In : Anti-Cancer Drugs. 23, 10, p. 1112-1117 6 p.

Research output: Contribution to journalArticle

High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults

Pedrazzoli, P., Ledermann, J. A., Lotz, J. P., Leyvraz, S., Aglietta, M., Rosti, G., Champion, K. M., Secondino, S., Selle, F., Ketterer, N., Grignani, G., Siena, S. & Demirer, T., Oct 2006, In : Annals of Oncology. 17, 10, p. 1479-1488 10 p.

Research output: Contribution to journalArticle

High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial

Pasquali, S., Colombo, C., Pizzamiglio, S., Verderio, P., Callegaro, D., Stacchiotti, S., Martin Broto, J., Lopez-Pousa, A., Ferrari, S., Poveda, A., De Paoli, A., Quagliuolo, V., Jurado, J. C., Comandone, A., Grignani, G., De Sanctis, R., Palassini, E., Llomboart-Bosch, A., Dei Tos, A. P., Casali, P. G. & 2 others, Picci, P. & Gronchi, A., Apr 2018, In : European Journal of Cancer. 93, p. 28-36 9 p.

Research output: Contribution to journalArticle

High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial

Pasquali, S., Colombo, C., Pizzamiglio, S., Verderio, P., Callegaro, D., Stacchiotti, S., Martin Broto, J., Lopez-Pousa, A., Ferrari, S., Poveda, A., De Paoli, A., Quagliuolo, V., Jurado, J. C., Comandone, A., Grignani, G., De Sanctis, R., Palassini, E., Llomboart-Bosch, A., Dei Tos, A. P., Casali, P. G. & 2 others, Picci, P. & Gronchi, A., Apr 1 2018, In : European Journal of Cancer. 93, p. 28-36 9 p.

Research output: Contribution to journalArticle

High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial

Pasquali, S., Colombo, C., Pizzamiglio, S., Verderio, P., Callegaro, D., Stacchiotti, S., Martin Broto, J., Lopez-Pousa, A., Ferrari, S., Poveda, A., De Paoli, A., Quagliuolo, V., Jurado, J. C., Comandone, A., Grignani, G., De Sanctis, R., Palassini, E., Llomboart-Bosch, A., Dei Tos, A. P., Casali, P. G. & 2 others, Picci, P. & Gronchi, A., Apr 1 2018, In : European Journal of Cancer. 93, p. 28-36 9 p.

Research output: Contribution to journalArticle

High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.

Pasquali, S., Colombo, C., Pizzamiglio, S., Verderio, P., Callegaro, D., Stacchiotti, S., Martin Broto, J., Lopez-Pousa, A., Ferrari, S., Poveda, A., De Paoli, A., Quagliuolo, V., Jurado, J. C., Comandone, A., Grignani, G., De Sanctis, R., Palassini, E., Llomboart-Bosch, A., Dei Tos, A. P., Casali, P. G. & 2 others, Picci, P. & Gronchi, A., Apr 1 2018, In : European Journal of Cancer. 93, p. 28-36 9 p.

Research output: Contribution to journalArticle

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J. Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 7 others, Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P. & Casali, P. G., Jun 1 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.

Research output: Contribution to journalArticle

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J-Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 7 others, Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P. & Casali, P. G., Jun 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.

Research output: Contribution to journalArticle

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J-Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 7 others, Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P. & Casali, P. G., Jun 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.

Research output: Contribution to journalArticle

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J-Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 7 others, Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P. & Casali, P. G., Jul 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.

Research output: Contribution to journalArticle

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J-Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 8 others, Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P., Casali, P. G. & Monti, M., 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.

Research output: Contribution to journalArticle

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

Gronchi, A., Ferrari, S., Quagliuolo, V., Martin-Broto, J., Pousa, A. L., Grignani, G., Basso, U., Blay, J. Y., Tendero, O., Diaz Beveridge, R., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 7 others, Stacchiotti, S., Bague, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P. & Casali, P. G., May 9 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.

Research output: Contribution to journalArticle

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J-Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 7 others, Stacchiotti, S., Bague, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P. & Casali, P. G., Jun 1 2017, In : The Lancet Oncology. 18, p. 812-822 11 p.

Research output: Contribution to journalArticle

How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience.

Marchesi, E., Cagnazzo, C., Quattrini, I., Piccinni Leopardi, M., Villa, C., Grignani, G., D'Ambrosio, L., Stacchiotti, S., Casali, P. G. & Picci, P., Feb 28 2017, In : Clinical Sarcoma Research. 7, 4, p. 1-6 6 p.

Research output: Contribution to journalArticle

How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience.

Marchesi, E., Cagnazzo, C., Quattrini, I., Leopardi, M. P., Villa, C., Grignani, G., D'Ambrosio, L., Stacchiotti, S., Casali, P. G. & Picci, P., 2017, In : Clinical Sarcoma Research. 7, p. 4 1 p.

Research output: Contribution to journalArticle

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib

Vincenzi, B., Nannini, M., Badalamenti, G., Grignani, G., Fumagalli, E., Gasperoni, S., D’Ambrosio, L., Incorvaia, L., Stellato, M., Spalato Ceruso, M., Napolitano, A., Valeri, S., Santini, D., Tonini, G., Casali, P. G., Dei Tos, A. P. & Pantaleo, M. A., Jan 1 2018, In : Therapeutic Advances in Medical Oncology. 10

Research output: Contribution to journalArticle

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib

Vincenzi, B., Nannini, M., Badalamenti, G., Grignani, G., Fumagalli, E., Gasperoni, S., D'Ambrosio, L., Incorvaia, L., Stellato, M., Spalato Ceruso, M., Napolitano, A., Valeri, S., Santini, D., Tonini, G., Casali, P. G., Dei Tos, A. P. & Pantaleo, M. A., 2018, In : Therapeutic Advances in Medical Oncology. 10, p. 1758835918794623

Research output: Contribution to journalArticle

Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour

D'Ambrosio, L., Palesandro, E., Boccone, P., Tolomeo, F., Miano, S., Galizia, D., Manca, A., Chiara, G., Bertotto, I., Russo, F., Campanella, D., Venesio, T., Sangiolo, D., Pignochino, Y., Siatis, D., De Simone, M., Ferrero, A., Pisacane, A., Dei Tos, A. P., Aliberti, S. & 2 others, Aglietta, M. & Grignani, G., Jun 1 2017, In : European Journal of Cancer. 78, p. 122-132 11 p.

Research output: Contribution to journalArticle

In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy

Russo, F., Mazzetti, S., Grignani, G., De Rosa, G., Aglietta, M., Anselmetti, G. C., Stasi, M. & Regge, D., May 2012, In : European Radiology. 22, 5, p. 1131-1139 9 p.

Research output: Contribution to journalArticle

Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression

Perissinotto, E., Cavalloni, G., Leone, F., Fonsato, V., Mitola, S., Grignani, G., Surrenti, N., Sangiolo, D., Bussolino, F., Piacibello, W. & Aglietta, M., Jan 15 2005, In : Clinical Cancer Research. 11, 2 I, p. 490-497 8 p.

Research output: Contribution to journalArticle

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients

Palmerini, E., Jones, R. L., Setola, E., Picci, P., Marchesi, E., Luksch, R., Grignani, G., Cesari, M., Longhi, A., Abate, M. E., Paioli, A., Szucs, Z., D'ambrosio, L., Scotlandi, K., Fagioli, F., Asaftei, S. & Ferrari, S., Jul 2018, In : Acta oncologica. 57, 7, p. 958-964 7 p.

Research output: Contribution to journalArticle

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients

Palmerini, E., Jones, R. L., Setola, E., Picci, P., Marchesi, E., Luksch, R., Grignani, G., Cesari, M., Longhi, A., Abate, M. E., Paioli, A., Szucs, Z., D’ambrosio, L., Scotlandi, K., Fagioli, F., Asaftei, S. & Ferrari, S., Jul 2018, In : Acta Oncologica. 57, 7, p. 958-964 7 p.

Research output: Contribution to journalArticle

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.

Palmerini, E., Jones, R. L., Setola, E., Picci, P., Marchesi, E., Luksch, R., Grignani, G., Cesari, M., Longhi, A., Abate, M. E., Paioli, A., Szucs, Z., D'ambrosio, L., Scotlandi, K., Fagioli, F., Asaftei, S. & Ferrari, S., Jul 1 2018, In : Acta Oncologica. 57, p. 958-964 7 p.

Research output: Contribution to journalArticle

Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity

Leuci, V., Maione, F., Rotolo, R., Giraudo, E., Sassi, F., Migliardi, G., Todorovic, M., Gammaitoni, L., Mesiano, G., Giraudo, L., Luraghi, P., Leone, F., Bussolino, F., Grignani, G., Aglietta, M., Trusolino, L., Bertotti, A. & Sangiolo, D., May 5 2016, In : Journal of Translational Medicine. 14, 1, 119.

Research output: Contribution to journalArticle

Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease

Gobbi, P. G., Pieresca, C., Ghirardelli, M. L., Di Renzo, N., Federico, M., Merli, F., Iannitto, E., Pitini, V., Grignani, G., Donelli, A., Carotenuto, M., Silingardi, V. & Ascari, E., Apr 15 1998, In : Blood. 91, 8, p. 2704-2712 9 p.

Research output: Contribution to journalArticle

Medical therapy in retroperitoneal sarcomas

Grignani, G., Sanfilippo, R. & Bertuzzi, A. F., Jan 1 2019, In : Updates in Surgery. p. 133-141 9 p.

Research output: Contribution to journalArticle

Painful pathologic fracture of the humerus: Percutaneous osteoplasty with bone marrow nails under hybrid computed tomography and fluoroscopic guidance

Anselmetti, G. C., Manca, A., Chiara, G., Tutton, S., Iussich, G., Gino, G., Grignani, G., Ortega, C., Moselli, N. & Regge, D., Jul 2011, In : Journal of Vascular and Interventional Radiology. 22, 7, p. 1031-1034 4 p.

Research output: Contribution to journalArticle

Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma

A Collaborative Effort from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG), Jun 2018, In : European Journal of Surgical Oncology. 44, 6, p. 810-815 6 p.

Research output: Contribution to journalArticle

Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma.

Tseng, W. W., Tsao-Wei, D. D., Callegaro, D., Grignani, G., D'Ambrosio, L., Bonvalot, S., Ethun, C. G., Cardona, K., Mullen, J. T., Canter, R. J., Mullinax, J. E., Gonzalez, R. J., van Coevorden, F., Albertsmeier, M., Dhanireddy, K. K., Renne, S. L., Gronchi, A. & (TARPSWG), A. C. E. F. T. T-A. R. S. W. G., Jun 1 2018, In : European Journal of Surgical Oncology. 44, p. 810-815 6 p.

Research output: Contribution to journalArticle

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models

Pignochino, Y., Capozzi, F., D'Ambrosio, L., Dell'Aglio, C., Basiricò, M., Canta, M., Lorenzato, A., Vignolo Lutati, F., Aliberti, S., Palesandro, E., Boccone, P., Galizia, D., Miano, S., Chiabotto, G., Napione, L., Gammaitoni, L., Sangiolo, D., Benassi, M. S., Pasini, B., Chiorino, G. & 2 others, Aglietta, M. & Grignani, G., Apr 28 2017, In : Molecular Cancer. 16, 1, 86.

Research output: Contribution to journalArticle

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.

Pignochino, Y., Capozzi, F., D'Ambrosio, L., Dell'Aglio, C., Basiricò, M., Canta, M., Lorenzato, A., Vignolo-Lutati, F., Aliberti, S., Palesandro, E., Boccone, P., Galizia, D., Miano, S., Chiabotto, G., Napione, L., Gammaitoni, L., Sangiolo, D., Benassi, M. S., Pasini, B., Chiorino, G. & 2 others, Aglietta, M. & Grignani, G., Apr 28 2017, In : Molecular Cancer. 16, 1, p. 1-15 15 p.

Research output: Contribution to journalArticle

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

Stacchiotti, S., Ferrari, S., Redondo, A., Hindi-Muniz, N., Palmerini, E., Vaz Salgado, M. A., Frezza, A. M., Casali, P. G., Gutierrez, A., Lopez-Pousa, A., Grignani, G., Italiano, A., LeCesne, A., Dumont, S., Blay, J. Y., Penel, N., Bernabeu, D., de Alava, E., Karanian, M., Morosi, C. & 10 others, Brich, S., Dagrada, G. P., Vallacchi, V., Castelli, C., Brenca, M., Racanelli, D., Maestro, R., Collini, P., Cruz, J. & Martin-Broto, J., 2019, In : The Lancet Oncology. 20, 9, p. 1252-1262 11 p.

Research output: Contribution to journalArticle

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

Stacchiotti, S., Ferrari, S., Redondo, A., Hindi, N., Palmerini, E., Vaz Salgado, M. A., Frezza, A. M., Casali, P. G., Gutierrez, A., Lopez-Pousa, A., Grignani, G., Italiano, A., LeCesne, A., Dumont, S., Blay, J. Y., Penel, N., Bernabeu, D., de Alava, E., Karanian, M., Morosi, C. & 10 others, Brich, S., Dagrada, G. P., Vallacchi, V., Castelli, C., Brenca, M., Racanelli, D., Maestro, R., Collini, P., Cruz, J. & Martin-Broto, J., Sep 2019, In : The Lancet. Oncology. 20, 9, p. 1252-1262 11 p.

Research output: Contribution to journalArticle